Energy Weakness Rolls Over To Biotech Stocks Update-1… 12/12

Crude Trade Roils Markets-But Biotech Is Still A Safe Haven Second Worst Week of the Year-Late Day Trading Hit By Selling As the market becomes more volatile we should look at how the energy trade is affecting other asset classes. Certainly materials and industrials are being hit over the past month. With respect to healthcare […]

Continue Reading 0

Rayno Biopharmaceutical Stocks-CBST Up 35%

Update 12/8 Biotech stocks hit new highs yesterday but could get choppy if overall market gets weak on bleak macro news. Cubist Pharmaceuticals (CBST) one of our original mid cap Biopharmaceutical picks soared 35% today to $100.75 on a $8.4B buyout by Merck (MRK).  

Continue Reading

Cruise Control Till Year End

Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio picks.

Continue Reading

Biotech Stocks Hit By Profit Taking-More Volatility Lies Ahead…Update-1

Bounce Back Day 12/2/14      FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio went green helped by Biogen Idec (BIIB) up 6.43% on Phase 1a data for an Alzheimer Diseases drug! The AD drug got […]

Continue Reading

Rayno Life Science: Market Update 11/26… Stocks Cruise To New Highs

NASDAQ leads -up 0.6% to 4787 The October correction of ~7% was a “headfake” as macro events scared many investor away Technology and Healthcare Stocks Lead The Way The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD. Biotech stocks are at new highs with all major ETFs […]

Continue Reading